Hold the Foam: Why Topical Budesonide Remains Relevant for IBD Therapy

Dig Dis Sci. 2020 Nov;65(11):3066-3068. doi: 10.1007/s10620-020-06199-1.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • 2-Hydroxypropyl-beta-cyclodextrin
  • Budesonide / adverse effects
  • Colitis, Ulcerative*
  • Gels
  • Glucocorticoids
  • Humans
  • Proctocolitis*

Substances

  • Gels
  • Glucocorticoids
  • 2-Hydroxypropyl-beta-cyclodextrin
  • Budesonide